OccamzRazor Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $11.5M

  • Investors
  • 32

OccamzRazor General Information

Description

Developer of an artificial intelligence-driven neuroscience therapeutics platform designed to take a computational approach to curing Parkinson's Disease. The company's platform consumes and analyzes various biomedical data sets, constructing an exhaustive knowledge graph representing all known information about Parkinson's disease, enabling healthcare professionals to drive downstream therapeutic insight and strategic drug development.

Contact Information

Website
www.occamzrazor.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 6th Avenue
  • Johnson & Johnson Innovation Labs
  • New York, NY 10013
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 101 6th Avenue
  • Johnson & Johnson Innovation Labs
  • New York, NY 10013
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OccamzRazor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A1) 25-Aug-2022 $11.5M Completed Pre-Clinical Trials
3. Accelerator/Incubator 19-Jul-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator 24-Mar-2020 $5.1M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 03-Oct-2018 $5.1M $5.1M Completed Pre-Clinical Trials
To view OccamzRazor’s complete valuation and funding history, request access »

OccamzRazor Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-5
Series A-4
Series A-3 82,644 $0.000100 $0.12 $0.12 1x $0.12 0.56%
Series A-2 61,962 $0.000100 $0.61 $0.61 1x $0.61 0.42%
To view OccamzRazor’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OccamzRazor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-driven neuroscience therapeutics platform designed to take a computational appro
Drug Discovery
New York, NY
12 As of 2025

San Francisco, CA
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OccamzRazor Competitors (4)

One of OccamzRazor’s 4 competitors is Verge Labs, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verge Labs Venture Capital-Backed San Francisco, CA
Deep Genomics Venture Capital-Backed Toronto, Canada
Numerion Labs Venture Capital-Backed San Francisco, CA
BenevolentAI Formerly PE-Backed Luxembourg, Luxembourg
To view OccamzRazor’s complete competitors history, request access »

OccamzRazor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OccamzRazor Investors (32)

Investor Name Investor Type Holding Investor Since Participating Rounds
10X Capital Venture Capital Minority
Daybreak Partners Venture Capital Minority
Angel (individual) Minority
Frontier Capital (China) Venture Capital Minority
Gaingels Venture Capital Minority
You’re viewing 5 of 32 investors. Get the full list »

Ready to get started?

Request a free trial

OccamzRazor FAQs

  • When was OccamzRazor founded?

    OccamzRazor was founded in 2015.

  • Where is OccamzRazor headquartered?

    OccamzRazor is headquartered in New York, NY.

  • What is the size of OccamzRazor?

    OccamzRazor has 12 total employees.

  • What industry is OccamzRazor in?

    OccamzRazor’s primary industry is Drug Discovery.

  • Is OccamzRazor a private or public company?

    OccamzRazor is a Private company.

  • What is the current valuation of OccamzRazor?

    The current valuation of OccamzRazor is .

  • What is OccamzRazor’s current revenue?

    The current revenue for OccamzRazor is .

  • How much funding has OccamzRazor raised over time?

    OccamzRazor has raised $16.6M.

  • Who are OccamzRazor’s investors?

    10X Capital, Daybreak Partners, , Frontier Capital (China), and Gaingels are 5 of 32 investors who have invested in OccamzRazor.

  • Who are OccamzRazor’s competitors?

    Verge Labs, Deep Genomics, Numerion Labs, and BenevolentAI are competitors of OccamzRazor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process